AR061197A1 - Cepas del virus 3 del dengue vivas atenuadas - Google Patents

Cepas del virus 3 del dengue vivas atenuadas

Info

Publication number
AR061197A1
AR061197A1 ARP070102282A ARP070102282A AR061197A1 AR 061197 A1 AR061197 A1 AR 061197A1 AR P070102282 A ARP070102282 A AR P070102282A AR P070102282 A ARP070102282 A AR P070102282A AR 061197 A1 AR061197 A1 AR 061197A1
Authority
AR
Argentina
Prior art keywords
atenuadas
cepas
vivas
dengue virus
attenuated dengue
Prior art date
Application number
ARP070102282A
Other languages
English (en)
Original Assignee
Sanofi Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur
Publication of AR061197A1 publication Critical patent/AR061197A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24111Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24111Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24161Methods of inactivation or attenuation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La invencion se refiere a cepas del virus de serotipo 3 del dengue vivas atenuadas las cuales han sido producidas por mutagénesis dirigida al sitio de una cepa del dengue 3 atenuada.
ARP070102282A 2006-06-07 2007-05-28 Cepas del virus 3 del dengue vivas atenuadas AR061197A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80410106P 2006-06-07 2006-06-07

Publications (1)

Publication Number Publication Date
AR061197A1 true AR061197A1 (es) 2008-08-13

Family

ID=38544276

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070102282A AR061197A1 (es) 2006-06-07 2007-05-28 Cepas del virus 3 del dengue vivas atenuadas

Country Status (3)

Country Link
US (1) US20080107685A1 (es)
AR (1) AR061197A1 (es)
WO (1) WO2007141259A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909286B1 (fr) * 2006-12-01 2012-06-08 Sanofi Pasteur Methode d'immunisation contre les 4 serotypes de la dengue
EP2473624B1 (en) 2009-08-31 2019-05-01 Gen-Probe Incorporated Dengue virus assay
US8895028B2 (en) 2012-07-20 2014-11-25 Arbovax, Inc. Methods and compositions for dengue virus 3 (DV3) infectious clone
AU2014281713A1 (en) 2013-06-21 2015-11-12 Merck Sharp & Dohme Corp. Dengue virus vaccine compositions and methods of use thereof
WO2016106107A2 (en) 2014-12-22 2016-06-30 Merck Sharp & Dohme Corp. Dengue virus vaccine compositions and methods of use thereof
KR102297300B1 (ko) * 2015-11-27 2021-09-02 케이엠 바이올로직스 가부시키가이샤 뎅기 바이러스 약독주를 뱅크화한 생바이러스, 및 그것들을 항원으로 하는 뎅기 백신

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000057904A2 (en) * 1999-03-26 2000-10-05 Walter Reed Army Institute Of Research Attenuated dengue-3 virus vaccine
ES2554254T3 (es) * 2000-02-16 2015-12-17 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Quimeras del virus del dengue 2 inmunógenas
ES2315221T3 (es) * 2000-05-30 2009-04-01 Mahidol University Cepas atenuadas del virus del dengue y su utilizacion en una composicion vaccinea.

Also Published As

Publication number Publication date
WO2007141259A1 (en) 2007-12-13
US20080107685A1 (en) 2008-05-08

Similar Documents

Publication Publication Date Title
AR061197A1 (es) Cepas del virus 3 del dengue vivas atenuadas
AR053913A1 (es) Cepa atenuada de dengue serotipo 1
ATE465719T1 (de) Oral zerfallende zusammensetzung von olanzapin oder donepezil
EA201000556A1 (ru) Спиропирролидины и их применение для борьбы с инфицированием посредством hcv (вирус гепатита с) и вич (вирус иммунодефицита человека)
CL2008003723A1 (es) Cepa de cladosporium cladosporioides, composicion biocida que comprende el microorganismo o sus esporas y metodo para controlar patogenos en hojas, frutos y espigas de plantas.
CL2011001277A1 (es) Compuestos derivados de n-oxiamidas espiroheterociclicas; su proceso de preparacion; composicion insecticida, acaricida, nematicida o molusquicida que comprende a dichos compuestos; metodo para combatir y controlar pestes; y compuestos intermediarios.
CR10528A (es) Proceso para producir poxvirus y composiciones de poxvirus
CR11583A (es) Arilpirrolinas insecticidas
UY34983A (es) Compuestos antivirales eficaces para inhibir la replicación del virus de la hepatitis c ("hcv") y c omposiciones relacionadas
CL2011001810A1 (es) Cepa de saccharomyces cerevisiae; composicion fitosanitaria que la comprende; y procedimiento de tratamiento o proteccion de plantas contra enfermedades provocadas por agentes patogenos.
CR11060A (es) Aril pirrolidinas insecticidas
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
GT201200249A (es) Cepa bacteriana aislada del genero burkholderia y metabolitos pesticidas del mismo
CL2011003039A1 (es) Mezcla sinergica de compuestos fungicidas y una cepa fungicida del genero bacillus spp; mezcla para combatir hongos nocivos fitopatogenos.
HN2006014095A (es) Forma cristalina ortorrombica del maleato de asenapina
AR053022A1 (es) Metodo para mejorar el desarrollo de plantas tolerantes o resistentes a los nematodos
CY1114883T1 (el) Καινοφανεις αντιβακτηριακοι παραγοντες για την αγωγη των κατα gram θετικων λοιμωξεων
BRPI0919048B8 (pt) Composições pesticidas
GT200800088A (es) Procedimiento para la preparacion de ferri-succinilcaseina
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
BRPI0713280A2 (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas
RS53907B1 (en) USE OF NIFURATEL FOR TREATMENT OF ATOPOBIUM-CAUSED INFECTIONS
ES2585242T3 (es) Cepas virales obtenidas del virus vaccinia Lister VACV-107 y usos de las mismas
CR11656A (es) Composiciones fungicidas con 3'-bromo-2,3,4-6'-tetrametoxi-2'-6-dimetilbenzofenona
AR060182A1 (es) Polisacaridos capsulares tipo 5 y tipo 8 de cepas s. aureus de sobreproduccion

Legal Events

Date Code Title Description
FA Abandonment or withdrawal